Add Company
Join Now

Prosidyan Revenue and Competitors

License our Company Data API

New Providence, NJ USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Prosidyan's estimated annual revenue is currently $3.3M per year.(i)
  • Prosidyan's estimated revenue per employee is $155,000

Employee Data

  • Prosidyan has 21 Employees.(i)
  • Prosidyan grew their employee count by -25% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.5M55-21%N/AN/A
#2
$0.2M10%N/AN/A
#3
$8.5M55-29%N/AN/A
#4
$108.5M5002%N/AN/A
#5
$0.8M50%N/AN/A
#6
$0.6M40%N/AN/A
#7
$14.7M68-23%$206.4MN/A
#8
$492.2M1503-15%$568MN/A
#9
$1.1M7-42%N/AN/A
#10
$4.5M290%N/AN/A
Add Company

What Is Prosidyan?

Prosidyan® is a medical device company focused on developing next generation bone graft substitute materials for orthopedic and spine applications. Prosidyan®, founded in 2009, uses proprietary microscopic fibers of bioactive glass to develop a family of synthetic bioactive bone graft substitutes. Prosidyan®’s latest product, FIBERGRAFT® BG Matrix, consists of FIBERGRAFT® BG Morsels in a bioactive fiber collagen based carrier, providing the direct connectivity of fibers with exponentially increased surface area and optimized resorption rate. It can be used as a strip or a putty and has preclinical results equivalent to autograft in a challenging rabbit un-instrumented posterolateral spinal fusion model. FIBERGRAFT® technology represents the future of synthetic bioactive bone grafts. For career opportunities: https://www.indeedjobs.com/prosidyan-inc/_hl/en_US

keywords:N/A

N/A

Total Funding

21

Number of Employees

$3.3M

Revenue (est)

-25%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.2M225%N/A
#2
$2.6M26-13%$4M
#3
$2M297%N/A
#4
$4.1M359%N/A
#5
$8.4M390%N/A